Article
Genotyping of factor V G1691A (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes.
Clinical chemistry - 1 Aug 2000
Hessner M J, Budish M A, Friedman K D
Abstract excerpt
BACKGROUND: The factor V G1691A Leiden (FVL) mutation is the most common known hereditary risk factor for venous thrombosis. METHODS: Third Wave Technologies, Inc. (Madison, WI) has developed a new microtiter plate-based assay that does not require PCR, restriction digestion, or gel electrophoresis. This technology system, termed the Invader(TM) assay, utilizes a 5' "invading" oligonucleotide and a partially...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
